Regulations.gov document
Reference 3: ISIS-2 (Second International Study of Infarct Survival) Collaborative Group…
Supporting & Related Material · FDA-1977-N-0023 · posted Jun 17, 2003
Key facts
| Document ID | FDA-1977-N-0023-0003 |
|---|---|
| Title | Reference 3 : ISIS-2 (Second International Study of Infarct Survival) Collaborative Group, "Randomized Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither Among 17,187 Cases of Suspected Acute Myocardial Infarction: ISIS-2," Lancet, 2:349-360, 1988. re: Background Material from FDA |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-1977-N-0023 |
| Posted | Jun 17, 2003 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: